×
ADVERTISEMENT

chikungunya

AE Reports Prompt FDA, CDC to Hit Pause on Ixchiq Vaccine

The FDA and CDC recently issued a joint advisory statement recommending a pause in the use of the Ixchiq ...

MAY 15, 2025

ACIP Recommends Bavarian Nordic’s Chikungunya Vaccine

The ACIP voted to recommend the Vimkunya vaccine for certain populations. However, the CDC has not acted yet on ...

APRIL 25, 2025

Bavarian Nordic Launches Chikungunya Vaccine

The new chikungunya vaccine, recombinant (Vimkunya, Bavarian Nordic A/S), the first VLP single-dose, prefilled ...

MARCH 18, 2025

FDA Approves First Chikungunya Vaccine for People as Young as 12 Years of Age

The FDA approved the Vimkunya (Bavarian Nordic), the first virus-like particle single-dose vaccine in the United ...

FEBRUARY 18, 2025

ACIP Recommends Chikungunya Vaccine for Certain Travelers and Laboratory Workers

The CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the chikungunya vaccine for use in ...

MARCH 1, 2024

Load more